| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 399.90B | 409.35B | 392.01B | 419.57B | 369.29B |
| Gross Profit | 74.81B | 71.82B | 69.42B | 81.78B | 79.11B |
| EBITDA | 54.91B | 56.21B | 49.34B | 56.62B | 63.23B |
| Net Income | 16.76B | 17.39B | 11.01B | 19.39B | 23.72B |
Balance Sheet | |||||
| Total Assets | 580.21B | 543.66B | 544.06B | 523.32B | 518.15B |
| Cash, Cash Equivalents and Short-Term Investments | 51.82B | 54.56B | 55.13B | 39.03B | 39.36B |
| Total Debt | 58.73B | 46.57B | 45.61B | 57.61B | 59.68B |
| Total Liabilities | 173.62B | 151.13B | 151.50B | 153.32B | 167.03B |
| Stockholders Equity | 396.65B | 383.03B | 383.45B | 362.23B | 343.88B |
Cash Flow | |||||
| Free Cash Flow | 4.53B | 13.05B | 38.73B | 19.80B | 14.87B |
| Operating Cash Flow | 53.54B | 46.97B | 57.88B | 41.45B | 35.06B |
| Investing Cash Flow | -48.32B | -30.51B | -15.68B | -25.98B | -23.16B |
| Financing Cash Flow | -9.84B | -16.78B | -28.36B | -17.32B | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥14.93T | 29.16 | 11.19% | 2.17% | 0.50% | -6.23% | |
64 Neutral | ¥966.40B | 22.83 | 4.79% | 4.21% | -4.09% | -27.31% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥315.37B | 18.59 | ― | 5.28% | -2.31% | -1.17% | |
60 Neutral | ¥534.37B | 163.36 | 1.02% | 3.37% | -1.80% | -85.21% | |
54 Neutral | ¥943.99B | 15.40 | 8.79% | 2.68% | -10.66% | 57.43% | |
53 Neutral | ¥1.49T | 128.39 | 1.09% | 3.50% | -15.96% | -74.31% |